A New Way to Measure How the Brain Uses Ketones as Fuel in Alzheimer’s Disease

Principal Investigator
Lydia LePage, MChem, PhD
University of California, San Francisco
San Francisco, CA, USA
About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$199,953
Active Dates
September 01, 2020 - August 31, 2022
Grant ID
A2020928F
Mentor(s)
Ken Nakamura, MD, PhD, University of California, San Francisco
Myriam Chaumeil, PhD, University of California, San Francisco
Goals
The ketogenic diet is thought to provide an alternative fuel for the struggling brain in Alzheimer’s disease – but is this fuel actually being used to make energy? Currently we have no way of knowing. We will develop a new way of imaging the brain to see if it is using the ketones as fuel and use the method to discover new insights into brain ketone metabolism in a mouse model of Alzheimer’s disease.
Summary
The ketogenic diet is being revisited as a treatment for Alzheimer’s disease, potentially providing replacement brain fuel as sugar use declines through disease development – but we need better tools to fully characterize and understand the diet’s effects. I will be investigating a non-radioactive, patient-safe ketone imaging probe to allow us to see what happens to ketones in the brain. I’ll also couple this with an existing probe of the glucose metabolism pathway, so we will get a more rounded picture of fuel use in the brain in mouse models of Alzheimer’s disease. Once we have the tools to understand the effects of ketones on the brain, we have more power to find new avenues for drug research, or improve personalization of treatments. My work will be in mice, but this imaging strategy has been used in clinical studies of other diseases such as prostate cancer, and so there is a clear path to translation to patients with Alzheimer’s disease.
Related Grants
Alzheimer's Disease Research
The Effects of Peripheral APOE2 on Alzheimer’s Disease Pathology and Pathways
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Guojun Bu, PhD
Current Organization
Hong Kong University of Science and Technology
The Effects of Peripheral APOE2 on Alzheimer’s Disease Pathology and Pathways
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Guojun Bu, PhD
Current Organization
Hong Kong University of Science and Technology
Alzheimer's Disease Research
Meningeal Lymphatics and APOE in Alzheimer's Disease
Active Dates
July 01, 2021 - June 30, 2024
Principal Investigator
Sandro Da Mesquita, PhD
Current Organization
Mayo Clinic Jacksonville
Meningeal Lymphatics and APOE in Alzheimer's Disease
Active Dates
July 01, 2021 - June 30, 2024

Principal Investigator
Sandro Da Mesquita, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
How "Good Cholesterol" May Help in Alzheimer's Disease
Active Dates
July 01, 2021 - June 30, 2025
Principal Investigator
Cheryl Wellington, BSc, PhD
Current Organization
University of British Columbia
How "Good Cholesterol" May Help in Alzheimer's Disease
Active Dates
July 01, 2021 - June 30, 2025

Principal Investigator
Cheryl Wellington, BSc, PhD
Current Organization
University of British Columbia